FDA Approves Voquezna for Erosive Esophagitis, GERD

TUESDAY, Nov. 7, 2023-- The U.S. Food and Drug Administration has approved Voquezna (vonoprazan), a novel potassium-competitive acid blocker, as a new treatment for adults for with all grades of erosive esophagitis or erosive gastroesophageal...